Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.
about
Normal tissue complication probability model parameter estimation for xerostomia in head and neck cancer patients based on scintigraphy and quality of life assessmentsUsing multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of Xerostomia after intensity-modulated radiotherapy for head and neck cancer.Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.A Nomogram to predict parotid gland overdose in head and neck IMRTParotid glands dose-effect relationships based on their actually delivered doses: implications for adaptive replanning in radiation therapy of head-and-neck cancer.LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma.Incorporating single-side sparing in models for predicting parotid dose sparing in head and neck IMRT.Sparing the region of the salivary gland containing stem cells preserves saliva production after radiotherapy for head and neck cancer.Differences in Parotid Dosimetry and Expected Normal Tissue Complication Probabilities in Whole Brain Radiation Plans Covering C1 Versus C2.The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia.Internal and external generalizability of temporal dose-response relationships for xerostomia following IMRT for head and neck cancer.Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.Early radiation-induced changes evaluated by intravoxel incoherent motion in the major salivary glands.
P2860
Q34498711-81373366-3441-47D2-899A-04E078689C4AQ35107930-9CD5DF61-BC32-4FBA-853B-685751F9C241Q35973996-BB7ADE0F-C3AF-4D44-A657-0996305BD912Q36982165-3E9A99D9-28D7-4D64-B9AC-B99451ECAC86Q37248648-FCB91EBD-4F4C-4CD6-9F24-960B0F26EBA6Q37743816-1894BFB6-18C5-4DCC-8968-8F96A089593AQ38634724-21BE64B0-C976-43F7-B7CD-A7570E15BC45Q41897016-2BB780D6-CFEA-451D-A438-19AACAFF80E2Q42062284-A3221746-0318-4C9D-9FFA-37B9873D9F8BQ45795379-77E75BFC-3950-4910-9861-A5A8F6ABE18CQ46313060-BE8A3C9E-0DEC-47EF-8FAB-3101AA3571CDQ49896415-33F7C5F4-BF4C-4BBC-A0E6-05AEE08CE485Q51097295-8188DD82-6E56-43FA-932A-8D0D2267C41F
P2860
Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Treatment planning constraints ...... ospectively collected dataset.
@ast
Treatment planning constraints ...... ospectively collected dataset.
@en
type
label
Treatment planning constraints ...... ospectively collected dataset.
@ast
Treatment planning constraints ...... ospectively collected dataset.
@en
prefLabel
Treatment planning constraints ...... ospectively collected dataset.
@ast
Treatment planning constraints ...... ospectively collected dataset.
@en
P2093
P2860
P1476
Treatment planning constraints ...... ospectively collected dataset.
@en
P2093
Adam Muggli
Aditya Apte
Allan Hovan
Anna Thompson
Carman Rabuka
Stephen Harrow
Ziad Saleh
P2860
P304
P356
10.1016/J.IJROBP.2011.04.020
P407
P577
2011-06-02T00:00:00Z